Robert Califf is one step closer to becoming the new head of the Food and Drug Administration after a Senate panel Thursday voted to advance his nomination.
The Senate Health, Education, Labor, and Pensions Committee voted 13-8 to support Califf, who previously led the agency in the final year of the Obama administration. The vote followed a December hearing that saw Califf get bipartisan support from committee members, despite some opposition over his drug industry ties.
Sens. Bernie Sanders (I-Vt.) and Maggie Hassan (D-N.H.) were the only members on the Democratic side to vote against Califf. Sen.